And these seem like faraway scenarios, but if you consider the  fact that we might not have antibiotics for many  people who have infections, we might consider the fact that we might want to allocate who actually gets to use some of these antibiotics over others, and some of these might have to be on the basis of clinical need, but also on the basis of pricing.
Ovo se može činiti kao daleki scenarij, ali ako razmotrimo činjenicu da možda nećemo imati antibiotika za mnoge ljude s infekcijama, mogli bi uzeti u obzir činjenicu da bi možda željeli raspodijeliti tko bi trebao zapravo korisiti neke od tih antibiotika od drugih, i to bi mogli biti na bazi  kliničke potrebe ali i na bazi cijene.